YOUTH CELLACTION
LIVE

Serial Number

79370193

Owner

YOUTH BIO GLOBAL, Co., Ltd.

Attorney

Gordon E.R. Troy, Esq.

Filing Date

Apr 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

YOUTH CELLACTION Trademark

Serial Number: 79370193 • Registration: 7464583

YOUTH CELLACTION is a trademark filed by YOUTH BIO GLOBAL, Co., Ltd. on April 20, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

YOUTH BIO GLOBAL, Co., Ltd. (5 trademarks)

1201-ho, Ace Twin Towers 2nd,

Entity Type: 03

Trademark Details

Filing Date

April 20, 2023

Registration Date

August 6, 2024

Published for Opposition

May 21, 2024

Goods & Services

Medical instruments for interstitial thermotherapy of biological tissue; medical apparatus and instruments, namely, containers for transporting samples containing living human cells; apparatus for the regeneration of stem cells for medical purposes; genetic testing apparatus for medical purposes; apparatus for use in medical analysis, namely, instrument for cartilage restoration, medical cell sampling instrument, cell testing and cell culture instruments; medical apparatus, namely, interstitial thermotherapy of biological tissue, DNA and RNA testing instrument; diagnostic apparatus for medical purposes for the detection of vascular diseases, cancer

Functional cosmetics being skin care preparations; anti-aging cosmetic preparations; make-up; body and beauty care cosmetics; sun block preparations being cosmetics; non-medicated toiletry preparations; skin cleansers; aromatics in the nature of essential oils; non-medicated soaps for personal use; toothpaste; cosmetic facial packs; perfume; cosmetics

Pharmaceutical agents affecting sensory organs for the treatment of wounds, ischemic vascular diseases, stem cells, bacterial infection, cancer; pharmaceutical preparations for health care for the treatment of wounds, ischemic vascular diseases, stem cells, bacterial infection, cancer; pharmaceutical agents affecting peripheral nervous system for the treatment of wounds, ischemic vascular diseases, stem cells, bacterial infection, cancer; dietetic supplements consisting of vitamins, minerals, amino acids and trace elements; dietary supplements; nutraceuticals for use as dietary supplements; biopharmaceuticals for the treatment of cancer; nutritional supplements; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; gene therapy products, namely, living tissue for transplant purposes and cytostatic for medical purposes; medicines for human purposes for the treatment of wounds, ischemic vascular diseases, stem cells, bacterial infection, cancer; multivitamin preparations; nutraceutical preparations for therapeutic or medical purposes for the treatment of wounds, ischemic vascular diseases, stem cells, bacterial infection, cancer; probiotic supplements

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 30, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 30, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 6, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Feb 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR